Korea Biotechnology Industry Organization and KOTRA Seek Companies for the Korea Pavilion at BIO USA 2027
- Input
- 2026-11-16 14:28:56
- Updated
- 2026-11-16 14:28:56

KBIO said on the 16th that it is jointly recruiting companies with KOTRA to participate in the Korea Pavilion at BIO USA 2027 through Dec. 11.
BIO USA is an annual event organized by the U.S. Biotechnology Innovation Organization (BIO), where global pharmaceutical and biotech companies and investors present drug pipelines and technologies and explore opportunities for technology transfers, joint research and investment. The 2027 event will be held June 7–10 at the Pennsylvania Convention Center in Philadelphia, U.S.
The two organizations will increase the number of companies jointly recruited for the 2027 Korea Pavilion by about 20%, from 26 last year to approximately 31. At BIO USA 2026, 51 Korean biotech companies participated in the integrated Korea Pavilion, and 29 companies presented their technologies and drug pipelines on the Open Stage.
Eligible applicants are domestic companies in all areas of the biotechnology industry, including biopharmaceuticals, drug development, clinical therapeutics, healthcare and digital services. Selected companies will receive government funding covering up to 70% of booth rental fees and basic booth setup costs. Support will also include production of a Korea Pavilion directory, partial assistance with shipping exhibition items, information on overseas buyers, and opportunities for local business consultations.
Applications are due by 6 p.m. on Dec. 11. Companies will be selected based on assessments of export performance, corporate competitiveness and suitability for the exhibition, among other criteria. Further details are available on the KBIO website and KOTRA's Global Exhibition Platform.
[email protected] Jung Sang-hee Reporter